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Abstract
Infectious diseases remain a remarkable health threat for humans and animals. In the past, the epidemiology,
etiology and pathology of infectious agents affecting humans and animals have mostly been investigated in
separate studies. However, it is evident, that combined approaches are needed to understand geographical
distribution, transmission and infection biology of “zoonotic agents”. The genus Bartonella represents a congenial
example of the synergistic benefits that can arise from such combined approaches: Bartonella spp. infect a broad
variety of animals, are linked with a constantly increasing number of human diseases and are transmitted via
arthropod vectors. As a result, the genus Bartonella is predestined to play a pivotal role in establishing a One Health
concept combining veterinary and human medicine.
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Background
The threat of infectious diseases to mankind has never
been greater than today. For the first time, political
leaders of the 41st “G7 summit” in Schloss Elmau/
Germany on June 7–8, 2015, set the topic “global health”
(including infectious diseases) as one of the key issues
on their agenda. In the past, health issues played only a
minor part in such international economic summits.
However, governments have now realized that public
health is an essential prerequisite for education, working
capacity and therefore the economic prosperity of
societies.
In this regard, it is important to recognize that human
health and animal health are closely linked. An estimated
75 % of emerging infectious diseases are zoonotic and
28 % vector-borne [1]. Global warming represents an add-
itional factor promoting the spread of these diseases as
the geographic range of some vectors and reservoir hosts
expands in response to a changing climate [2].
To respond to these challenges, the One Health con-
cept aims to establish interdisciplinary collaborations
between medical, veterinary and environmental re-
searchers as well as public health officials for the early
detection of health hazards affecting both humans and
animals and to fight them on multiple levels. The genus
Bartonella represents a prototypical example for zoo-
notic pathogens as Bartonella species are infectious
agents for humans and animals. High pathogen preva-
lence and severe courses of infection raise the import-
ance to investigate possible routes of transmission and
to combat infections.
The genus Bartonella: a diverse and expanding
group of bacteria
The bacterial genus of Bartonella is comprised of
Gram-negative, slow growing and facultative intracel-
lular pathogens that infect mainly mammalian hosts
and are often transferred via blood sucking arthropod
vectors. Bartonella infections of humans and animals
are often characterized by an intraerythrocytic bacteremia.
At least 20 species are known to cause host-specific
intraerythrocytic infections in their specific mammalian
reservoir hosts, including the human-specific pathogens
Bartonella quintana and Bartonella bacilliformis, the
agents of trench fever and Oroya fever, respectively. A sec-
ondary tissue phase can be associated with development
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of vasculoproliferative lesions, e.g. bacillary angiomatosis
(Bartonella henselae, B. quintana) or verruga peruana (B.
bacilliformis) and may play a role in various other dermal
conditions [3–7].
Molecular epidemiology techniques have revealed a
remarkable diversity within the genus Bartonella. A wide
variety of Bartonella spp. specialized to various mamma-
lian hosts and transferred by specific arthropod vectors
have been identified over the years and the prevalence of
infection appears to be widespread across species and
geographic regions. At least 13 species of Bartonella
have been identified as pathogenic to humans with three
species responsible for most of the clinically relevant
infections in humans: B. bacilliformis, B. quintana and
B. henselae [6].
Bartonella spp. infections are often chronic or asymp-
tomatic in their reservoir hosts. Bacteria have been
shown to infect erythrocytes, endothelial cells, macro-
phages and even human stem cells [8–17]. The infection
of erythroctyes is host-specific and mediated by the so-
called “Trw”-type 4 secretion system which facilitates
host-restricted adhesion to erythrocytes [18]. Localized
tissue manifestations may occur in reservoir and inci-
dental hosts and the growth of bacteria in vascular tissue
can lead to angioproliferative tumors and inflammation
[5, 6, 12, 19]. The ability of Bartonella spp. to persist
within immunoprivileged intracellular habitats is prob-
ably a key factor contributing to the establishment of
chronic infections; however, the cyclic release of bacteria
to the blood stream or the hemolytic activity of some
species can also result in dramatic illnesses such as
trench fever or Oroya fever, respectively [20]. The pres-
ence of Bartonella spp. in the blood stream of infected
hosts or within the erythrocytes also facilitates their
transfer via ingestion along with the blood meal of
arthropod vectors [5, 21].
Bartonella spp. infections in animals
Cat infections
Cats are the main reservoir host for the species B. hen-
selae, B. clarridgeiae (both of which can cause cat
scratch disease) and B. koehlerae (a causative agent of
endocarditis in humans) [22–24]. Infected cats are
often clinically asymptomatic although they suffer from
relapsing bacteremia over long periods of time [25].
Co-infections with more than one Bartonella species
are not uncommon [26–29].
Transmission of Bartonella spp. among cats occurs via
arthropod vectors, predominantly fleas. Uninfected cats
kept together with infected cats in a specific ectoparasite-
free environment do not become seropositive emphasizing
the importance of arthropod vectors in the transmission
of disease. Furthermore, the transmission via arthropod
vectors appears to be essential as no direct transmission
of B. henselae from cat to cat has been documented ex-
perimentally and flea-prevention measures have been
shown to be effective in preventing pathogen transmission
[30–35]. Prevalence of infection is highest in warm, moist
areas with a higher ectoparasite burden (0 % in Norway
versus 68 % in the Phillipines) [8, 22, 30, 36–38]. Up to
50 % of all cats (stray and pet) living in regions where fleas
are endemic, harbor bacteremic Bartonella infections [26,
28]. Usually, cats are bacteremic for weeks or months but
even longer infection intervals are possible. Young cats
are more likely to be bacteremic than old cats and stray
cats more than pet cats [8, 22, 23]. Cats were tested in
several regions of Spain, for B. henselae seroreactivity
and 50 % were shown to be positive. It is known, how-
ever, that serum antibodies have a limited value for the
detection of active infections. In the same study, DNA
of Bartonella spp. was detected in 4.4 % of the exam-
ined cat fleas [39]. Bartonella spp. have also been
isolated from cat blood in various other locations
throughout the world (e.g. from San Francisco/USA,
North Carolina/USA, Hawaii/USA, Japan, Sydney, New
Zealand, the Netherlands, France, Indonesia and
Germany) [26, 28, 40–49].
Those Bartonella strains which have been isolated
from healthy cats were usually not of the same genetic
background as those strains detected from infected
humans. Some of the feline strains were never found on
patients and therefore might be less pathogenic for
humans [50, 51].
Although healthy cats can be infected with B. henselae
and B. clarridgeiae for months or even years, there is
evidence that cats may also suffer from the persistent in-
fection [26]. Especially infections with Bartonella spp.
that are not believed to be specifically adapted to the cat
as reservoir host (e.g. Bartonella vinsonii subsp. berkhof-
fii) can result in more serious clinical symptoms, e.g.
osteomyelitis [30, 31, 52]. Several seroepidemiological
studies indicated a correlation between seroreactivity
and stomatitis, kidney- and urinary tract-diseases and
uveitis [26, 53–55]. Another survey found that stomatitis
is associated with the detection of Bartonella spp. but
not with seroreactivity and revealed no association with
uveitis, neurological symptoms and chronic kidney dis-
eases; however, a weak association between seroreactivity
and idiopathic feline lower urinary tract disease was
detected [56]. Cats experimentally infected with B.
henselae or B. clarridgeiae were found to suffer from
fever, eosinophilia, lymphadenomegaly and anemia.
Perinatal transmission was not described but repro-
ductive disorders were observed. Furthermore, some
cats suffered from transient neurological disorders,
endocarditis and focal myocarditis [26, 57–62].
Isolation of Bartonella spp. has been possible from
cats whose owners suffered from cat scratch disease and
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bacillary angiomatosis and B. clarridgeiae was isolated
from a kitten that had caused cat scratch disease in a
veterinarian [25, 26, 40, 63]. Bartonella quintana was
found in the mouth of a domestic cat and there are re-
ported cases of humans suffering from B. quintana in-
fections where no louse infestation was verifiable but
contact with cats was reported [30, 64]. In one case B.
qintana was detected in a woman and two cats, one of
which had bitten the woman previously providing further
evidence for the incidental zoonotic transmission of Bar-
tonella between animals and humans [65]. Antimicrobial
treatment for pathogen eradication in cats is not broadly
recommended; therefore, ectoparasite-control (e.g. collars
containing acaricides) is crucial as the main instrument to
lower the Bartonella prevalence in cats and therefore re-
duces the risk of pathogen-transmission to humans [30, 35].
Dog infections
Dogs represent an incidental host for Bartonella and
two species are known to cause clinically apparent infec-
tions: B. vinsonii subsp. berkhoffii, causing endocarditis,
arrhythmias, myocarditis, granulomatous lymphadenitis
and granulomatous rhinitis, and B. henselae causing
peliosis hepatis [66–71]. In a study from the United
States surveying Bartonella bacteremia in dogs, B. hense-
lae was found in 30 of 61 infected dogs [72]; however,
there are also rare cases in which other Bartonella spp.
have caused disease in dogs: B. clarridgeiae, B. washoen-
sis and B. quintana were isolated from dogs suffering
from endocarditis [8, 22, 23]. To date, all Bartonella spp.
identified in sick dogs are also known as pathogenic or
potentially pathogenic infectious agents for humans and
this observation led to the suggestion that dogs might
act as useful sentinel species and important comparative
models for human infections [22, 73].
Domestic dogs are generally incidental hosts for B.
henselae with a reported seroprevalence of ~10 % in
healthy dogs in the United States and ~27 % in sick dogs
[30, 74]. Similar to cat epidemiology, seroprevalence
increases in warmer regions [30]. Bartonella henselae, B.
quintana, B. vinsonii subsp. berkhoffii and B. bovis have
been detected in mouth swabs from dogs and there is
some evidence that dogs may be able to transmit B. hen-
selae to humans via bites [22, 30, 37, 75]. Because of the
prolonged bacteremia of B. vinsonii subsp. berkoffii in
dogs, they are suspected to represent the reservoir host
of these bacteria and seroreactivity of dogs against B.
vinsonii subsp. berkoffii is found worldwide [22, 26, 32].
In Gabon, B. clarridgeiae was also isolated from ~2 % of
the examined dogs indicating that these animals may
represent a potential reservoir host for Bartonella spp. in
Africa [76].
Serological surveys suggest that B. vinsonii subsp. ber-
khoffiimay also cause immuno-mediated hemolytic anemia,
neutrophil or granulomatous meningoencephalitis, neutro-
phil polyarthritis and uveitis in dogs [8, 22]. Bartonella vin-
sonii subsp. berkhoffii can cause endocarditis, especially in
large breed dogs with a predisposition for aortic valve in-
volvement. Intermittent lameness and fever of unknown
origin can occur several months before endocarditis. Myo-
carditis without an associated endocarditis is also possible
and may result in arrhythmias, syncope or sudden death
[26, 67]. To detect Bartonella spp. as the causative agent of
infectious endocarditis in dogs, diagnostic PCRs should be
performed from blood or heart valve specimen as blood
cultures often remain negative [77, 78]. High antibody-
titers and characteristic lesions in echocardiography are
also suspicious for Bartonella endocarditis. In most
cases, Bartonella infect the aortic valve causing aortic
insufficiency leading to severe chronic heart failure
and arrhythmias [66–68, 77, 79, 80].
Infections of other mammals
There are many publications describing Bartonella infec-
tions of numerous mammals and even reptiles. For in-
stance, Bartonella spp. have been detected in a wide
variety of wild and domestic animals throughout the
world including, e.g. mountain lions, bobcats, coyotes,
grey foxes, elks, mule deer, cougars, rabbits, several ro-
dent species, cattle, belugas, bats and porpoises. How-
ever, it is unclear which diseases if any are associated
with such infections and if these animals play a role as
potential reservoir hosts. [26, 30, 81–92].
Bartonella spp. infections of humans
The first human pathogenic Bartonella species to be
identified in the early 1900s was B. bacilliformis. This
human-specific bacterium causes a biphasic disease
characterised by a primary hemolytic fever (“Oroya
fever”) with high mortality (up to 90 %), followed by a
chronic vasculoproliferative tissue phase (“verruga per-
uana”). Pathogens are transmitted by the sand fly (Lutzo-
myia verrucarum). The human body louse (Pediculus
humanus humanus) transmits B. quintana, a second hu-
man pathogenic Bartonella species which emerged as a
major agent of disease causing debilitating cyclic fever
(“trench fever“) during World War I. Today, trench fever
occurs mainly in the homeless population or among
drug addicts. Endocarditis, generalized lymphadenopathy
and bacillary angiomatosis are symptoms of B. quintana
infections in immunocompromised people [93–100].
Of the three most significant human pathogenic Barto-
nella species B. henselae is the most common symptom-
atic infection causing agent identified in the modern
clinical setting. Bartonella henselae infection is the cause of
multiple clinical entities in humans and infections result in
differential disease outcomes often depending on the
immune status of the patient. Humans become infected
Regier et al. Parasites & Vectors  (2016) 9:261 Page 3 of 12
via the scratches or bites of infected cats contaminated with
infected flea feces or are directly contaminated with in-
fected blood. Dogs are also suspected to be an additional
reservoir for B. henselae transmission to humans [41]. In
immunocompetent patients, infections normally cause cat
scratch disease which is often self-limiting with no need for
antibiotic treatment. Typically, two to three weeks after in-
fection, a unilateral lymphadenitis in the draining region of
the lymph node near the site of inoculation can be ob-
served. In ~10 % of the cases, the lymph node forms a fis-
tula where pus is draining. Other symptoms include
chronic lymph node swelling, fever, headache, skin and
mucosal lesions near the inoculation site and splenomeg-
aly. “Blood-culture negative”-endocarditis, oculoglandular
involvement (“Parinaud’s syndrome”), encephalopathy,
neuroretinitis and osteomyelitis are described as complica-
tions of infection [101]. Recurring or systemic infections
can be treated with macrolides. In immunocompromised
hosts, chronic infections can occur, leading to angioproli-
ferative diseases like bacillary angiomatosis and peliosis
hepatis which can be fatal if not treated [6, 19].
Several Bartonella spp. have been reported as cause of
fever of unknown origin and culture-negative endocarditis
in humans and animals [102–105]. In humans, endocardi-
tis caused by B. henselae, B. quintana, B. elizabethae, B.
vinsonii subsp. berkhoffii, B. vinsonii subsp. arupensis, B.
koehlerae, B. alsatica, B. washoensis and Candidatus B.
mayotimonensis have been reported [24, 106–114]; how-
ever, human endocarditis cases are most often associated
with B. henselae and B. quintana [79, 80, 115]. In most
cases, high anti-Bartonella-IgG antibody-titers can be
detected [102, 116].
Co-infections with more than one Bartonella spp.
(even in immunocompetent patients) [117–119] and
with other zoonotic bacterial species have been reported.
Co-infections with Borrelia burgdorferi (sensu lato) and
B. henselae were described in patients with atypical neu-
roborreliosis [120–122]. Furthermore, surveys showed
the occurrence of co-infections with B. henselae in
people suffering from persistent symptoms after borre-
liosis treatment where ticks might have been the source
of infection [121]. The transmission of multiple patho-
gens via co-infected vectors might contribute to atypical
disease progression and should be considered for the
diagnosis of tick-borne diseases [121, 123, 124]. How-
ever, it must be stated that the occurrence of chronic,
atypical tick-borne co-infections in patients with
chronic, nonspecific illnesses is highly controversially
discussed. As reviewed by Lantos & Wormser, in
most reported cases of Bartonella and Borrelia co-
infections, laboratory diagnostics were not properly
performed [125].
Different population groups are exposed to animals and
arthropod vectors in variable dimensions. In particular,
veterinarians, veterinary technicians or zookeepers might
be at increased risk of infection with Bartonella spp. [119,
126]. For example, one case of B. vinsonii subsp. berkhoffii,
transmission to a veterinarian was likely caused by a nee-
dle puncture injury [127]. Bartonella infections have even
been suspected to have been a contributing factor in the
death of two veterinarians in 2013 [128]. In an epidemio-
logical study, Bartonella DNA was also detected in the
blood of 28 % of veterinary workers whereas no Barto-
nella was detected in control subjects [126]. The preva-
lence of Bartonella infections has also been found to be
elevated in other risk groups. In a recent study in
Germany B. henselae IgG antibodies were found in ~45 %
of forestry workers which may be due to a higher contact
with arthropods which is inevitable during forest work
[129]. From a One Health perspective, the identification
of possible vectors and means of Bartonella transmission
is crucial to reduce occupational hazards in certain risk
groups and prevent such cases of Bartonella transmission
in future.
Blood transfusion has also been identified as a risk
factor for the transmission of Bartonella infections. The
transmission of infection via blood transfusion was first
shown 20 years ago in cats [58] and a very recent study
from Brazil has also indicated a ~3 % prevalence of
Bartonella spp. in asymptomatic human blood donors.
Remarkably, the results of this study found that profes-
sionals with animal contact were seven times more likely
to harbor Bartonella than other blood donors and indi-
viduals with cat contact or a history of tick bite were
three to four times more likely to be infected with Barto-
nella spp. [130]. Considering that patients receiving
blood transfusions are already in a state of weakened
health, screening of blood donors for Bartonella infec-
tions, especially in certain risk groups should be consid-
ered to prevent transmission of infection.
Vector transmission of Bartonella spp.
The transmission cycle of bartonellosis is typical for
vector-borne diseases. Typically, infections are charac-
terized by persistent intraerythrocytic bacteremia within
the reservoir host. Infected blood is ingested by the
blood sucking arthropod vector and subsequently trans-
mitted to a further reservoir or incidental host. To date,
vector-competence of several arthropods has been
proven for Bartonella spp. transmission and additional
vectors competencies are suspected in many more.
Flea transmission of Bartonella spp.
The cat flea (Ctenocephalides felis) represents the main
vector for B. henselae infection among cats. Its vector-
competence for B. henselae transmission is experimentally
proven and its presence is essential for the maintenance of
B. henselae infection within the cat population. The
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contamination of the flea-feeding wound, or other wounds
such as scratches or bites with contaminated flea feces has
been identified as an important transmission route among
hosts including cats and humans [30, 33, 96, 131–133].
Bacteria are replicating in the flea’s intestine and are
secreted with the feces over the life-span of the flea
(~12 days). The excreted flea feces contain B. henselae
within 24 h of a blood meal [134].
Further supporting the importance of the flea as a
vector of B. henselae transmission, epidemiological
studies have shown an increased risk of B. henselae
infection in cats suffering from flea infestation and
the use of flea-prevention collars has also been shown
to be effective in preventing the transmission of B.
henselae infection from cat to cat [35]. Once infected,
B. henselae bacteremia in cats can last for weeks,
months or even longer than one year supporting fur-
ther vector-transmission [22, 23, 29, 39, 132, 135,
136]. In addition to B. henselae, cats are susceptible
to infections with B. quintana, B. koehlerae, B. clar-
ridgeiae, B. vinsonii subsp. berkhoffii and B. bovis
which have also been detected in cat fleas. With the
exception of B. bovis, these species can also be patho-
genic to humans [6, 30, 52, 137]. Flea control is
highly recommended in endemic areas to reduce the
pathogen exposition of cats and humans [39].
In addition to the cat flea various other flea spe-
cies may also play important roles in Bartonella
transmission. Bartonella spp. were detected in sev-
eral flea species collected from bats and different
rodents [30, 96, 138–144]. Vector-competence, how-
ever, has not been confirmed experimentally for
these species.
Louse transmission of Bartonella spp.
The human body louse (Pediculus humanus humanus)
represents the vector of human to human-transmission
of B. quintana. Environmental factors supporting louse
infestation such as unhygienic living conditions lead to
an increased risk of infection. In the past, infections with
B. quintana were a severe medical problem in the
trenches and in prisoners of war camps of World War I
from which the name “trench fever” arises. Today,
mostly homeless people or drug addicts are affected
resulting in the term “urban trench fever” [99, 145]. The
vector becomes infected when adult lice feed on
bacteremic hosts. Bartonella quintana reaches the louse
gut and can infect humans when bite sites or other
wounds are contaminated with infected louse feces
[30, 64, 65, 96, 97, 146]. Bartonella spp. have also
been detected from several other louse species (e.g.
Neohaematopinus sciuri, Hoplopleura sciuricola, Pedi-
culus humanus capitis and others) which may also
serve as vectors [96, 139, 147, 148].
Sand fly transmission of Bartonella spp.
The sand fly (Lutzomyia verrucarum) transmits B. bacilli-
formis from humans to humans and its vector-competence
has been proven experimentally [96, 98, 149–151]. The
occurrence of the disease is strictly limited to the Peruvian
Andes where the vector is endemic. However, it should be
considered that climate change may extend the distri-
bution area of this vector and thereby increase the
spread of B. bacilliformis.
Tick transmission of Bartonella spp.
Ticks are known to act as vectors for many different
bacterial, protozoan and viral pathogens. Hard ticks (e.g.
Ixodes spp., Dermacentor spp.) usually feed three times
during their life-cycle and can possibly be infected with
different pathogens during every blood meal. Hosts can
be bitten by ticks several times during their lifetime
presenting multiple opportunities for pathogen transmis-
sion [152–154]. Several studies have detected the pres-
ence of Bartonella spp. in various tick species from
around the world [26, 84, 93, 120, 121, 123, 138, 152,
155–168]. The prevalence of Bartonella DNA in hard
ticks in Europe has been shown to be as high as 40 %
[158]. In a recent study conducted in Finland, ticks were
found to contain no detectable Bartonella DNA whereas
DNA of Borrelia spp. was found frequently at ~ 19 %
[169]. On the other hand, Bartonella DNA was detected
in ~2 % of ticks collected in a recent study from Austria
[170]. Figure 1 displays the percentage of ticks found to
harbor Bartonella in different studies. Overall, in ~15 %
of ticks studied Bartonella DNA was detectable.
Vector competence has been demonstrated experi-
mentally by the use of artificial tick-feeding procedures
for B. henselae [171] and a murine B. birtlesii infection
model [172]; however, vector competence of naturally
infected ticks has still not been confirmed.
Bartonella DNA has been detected in hard ticks re-
moved from dogs. However, as DNA was detectable in
only some but not all ticks removed from one particular
dog, the infection of the tick may have been acquired
from another source previously [173]. Furthermore,
several studies indicate co-transmission of Barto-
nella with other tick-borne pathogens (e.g. Ehrli-
chia, Babesia) in dogs [66, 174–178]. In a study
surveying dogs with endocarditis from California, all
dogs that were infected with Bartonella were also
seroreactive to Anaplasma phagocytophilum, another
tick-borne pathogen [77].
In two cases, B. henselae DNA was detected in ticks
collected from the home of patients which suffered from
Lyme disease and which did not respond to a Borrelia-
specific antibiotic therapy. In another study, Bartonella
DNA was detectable in human blood after tick bites and
recently, B. henselae and three other animal-associated
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Bartonella species (B. doshiae, B. schoenbuchensis and B.
tribocorum) were isolated from patients suffering from
undifferentiated chronic illness and who had reported
tick bites [121, 179, 180].
Several case reports of B. henselae infections of
humans have been published where no or very limited
cat contact was reported, limiting the possibility of
transmission via cats or cat fleas. Authors concluded
that transmission via arthropod vectors (e.g. ticks) may
provide an alternative explanation [96, 181].
The most important reservoir hosts for tick-borne
pathogens are small rodents as they are the preferred
hosts of tick larvae and nymphs. Several Bartonella spp.
have been detected in these small mammals further
supporting the possibility that ticks may represent a
vector for Bartonella transmission [84, 87, 152–154, 162,
182, 183]. Bartonella spp. have also been isolated from
cattle and mule deer in North America. As ruminants
are rarely infested with fleas, ticks seem to be more
likely to transmit these pathogens to these animals [81].
Nevertheless, it must be mentioned that the transmis-
sion of Bartonella spp. via ticks to humans and animals
is still controversially discussed. Clearly, Bartonella
DNA which was found in several tick species in multiple
studies does not prove the presence of viable bacteria.
Therefore, some researchers doubt heavily that Barto-
nella spp. are transmitted by ticks [125, 184]. Further-
more, concerns about the relevance of experimental tick
transmission studies performed with an artificial feeding
system [171] have been raised [184]: the amount of
colony forming units in the blood was criticized to be
much higher than it would be in natural infected
bacteremic cats and the B. henselae strain that was used is
not representative for Bartonella strains found in nature
[184]. Building on these points, the authors conclude that
neither of these studies demonstrated transmission of Bar-
tonella spp. from ticks to mammalian hosts [125]. At least
for B. birtlesii, tick transmission was proven in a murine
infection model [172] whereas a bona fide tick transmis-
sion of B. henselae has not been demonstrated so far.
The role of other arthropods in the transmission
of Bartonella spp.
Bartonella species have been found in biting flies collected
from cattle in California: B. bovis was detected in a horn fly
(Haematobia spp.) and B. henselae was found in a stable fly
(Stomoxy spp.) [185]. Several studies found Bartonella spp.
in mites collected from rodents and bats from Korea, Egypt
and Costa Rica [96, 162, 186]. Deer keds (Lipoptena maza-
mae and Lipoptena cervi) were shown to be infected with
B. henselae and B. schoenbuchensis [30, 187–189]. Lipop-
tena species usually feed on deer but were also found on
horses, cattle and humans. Bartonella schoenbuchensis was
detected in Lipoptena cervi from a deer (Capreolus capreo-
lus) in Germany and is suspected to be the causative agent
of deer ked dermatitis in humans [190]. Bartonella was also
found in several other species of the family Hippoboscidae
indicating that they may play a role in the transmission of
these bacteria [96, 191]. However, no experimental trans-
mission studies with these species have been performed
nor do any data exist on the transmission of B. schoenbu-
chensis by Lipoptena spp. to humans.
Fig. 1 Percentage of ticks found to harbor Bartonella spp. DNA (literature review). Presence of Bartonella spp. was determined via molecular
techniques. Overall, Bartonella spp. were found in ~14.88 ± 15.80 % of ticks. Countries in which ticks were collected are depicted within
the diagram
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The need for scientific One Health approaches in
Bartonella research
When discussing transmission of Bartonella spp. from
animals to humans, e.g. via arthropod vectors, a more
integrative approach elucidating Bartonella prevalence
in vectors as well as the infection status of animals and
humans would clearly help to increase understanding of
Bartonella infection dynamics, infection risk and prevent
speculative and non-evidence-based conclusions. Such
an approach might, for instance, include the investiga-
tion of the prevalence of Bartonella DNA or (even more
reliable) of viable Bartonella species in feeding ticks,
combined with parallel detection of these pathogens via
direct detection or seroprevalence in animals (e.g. pets)
and humans (e.g. pet owners). Figure 2 shows this con-
cept of such a One Health approach.
For instance, a coordinated set of data might include
(i) the pathogen-DNA status of questing ticks (with
bacterial, e.g. Bartonella 16S-rDNA sequences; analyzed
by conventional PCRs or metagenomics analysis), (ii) the
direct detection of these pathogen(s) or detection of
pathogen-specific (e.g. Bartonella) antibodies in animals
(arguing for infection of the pet), and (iii) the direct
detection of these pathogen(s) if feasible or the deter-
mination of the respective pathogen-specific antibodies
in humans (e.g. pet owner) in parallel (arguing for a
previous or present infection).
First incidental results from a clinical case revealed
interesting findings: In a female, adult, half-engorged I.
ricinus tick (black forest, Germany) which was feeding
for ~1–2 days on a cat, Bartonella-DNA was detected
via nested-PCR. Sequence analysis revealed most likely
the presence of B. henselae 16S-rDNA (99 % sequence
homology). For medical reasons, a serum sample from
the cat was taken (because of unspecific illness). Im-
munofluorescence testing revealed cat antibody titers of
1:640 whereas no specific B. henselae-antibodies were
detected in the pet owner. This setting might be inter-
preted as follows: The questing I. ricinus tick was prob-
ably ingesting B. henselae-containing cat blood as anti-B.
henselae IgG antibodies were detectable. The pet owner,
however, had no serological evidence for having been
exposed to B. henselae. As a further option, a chronic B.
henselae infection of the cat might additionally be
confirmed (e.g. via PCR-analysis of peripheral blood).
The application of such One Health approaches in pro-
spective scientific studies would be useful to assess the
real risk of transmission of Bartonella spp. from pets to
pet owners and to clarify the role of ticks in this process.
Conclusions
The cumulative data collected in many studies and
conducted in several countries throughout the world
indicate that infections with Bartonella spp. might
represent an underappreciated danger for human and
animal health. A great deal more research is needed to
specify arthropod vectors and characteristics of dis-
eases caused by Bartonella species. To date, strict
Fig. 2 One Health concept for detecting of Bartonella infections in humans and domestic animals. Fleas transmit B. henselae to cats. Transmission
of B. henselae by ticks, e.g. Ixodes ricinus a to cats b or humans c is assumed but controversially discussed. Bartonella DNA can be detected in
ticks via real-time PCR or conventional PCR d. Finally, B. henselae infections of cats and humans can be diagnosed by indirect immunofluorescence
analysis (anti-B. henselae-IgG: green, e, f)
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ectoparasite-control is highly recommended to lower
the risk of Bartonella infection from arthropod vectors to
domestic animals and pets, thereby preventing pathogen
transmission from animals to human owners. Overall,
these results demonstrate that reliable data about vector
transmission of Bartonella spp. from animals to humans
can only be generated through the application of scientific
One Health approaches which take into account the
epidemiological factors and interactions of humans, ani-
mals and their environments as an integrated system.
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